News

President Biden issued an Executive Order on Monday to create a National Biotechnology and Biomanufacturing Initiative.

Paris-based Nutropy raises $2M, Arsenal raises $220M & a biosensor for VX nerve agent.

Vilya, a protein design company, just launched with $50M in Series A funding.

Electronics and computer programming have made experiments better and cells smarter.

A plastic-eating enzyme can break down polyethylene terephthalate (PET), the same plastic used to make water bottles and textiles, at rates that vastly exceed prior reports.

Hundreds of millions were raised for, and by, anti-aging companies. And a new protein improves mitochondrial DNA editing.

A Ginkgo earnings call reveals financial packages for top executives, biotech stocks are in decline & a more flexible CRISPR system could be used to correct a wide range of disease-causing genetic variants.

A one-shot gene therapy for hemophilia A is superior to standard treatment, according to results from a phase 3 clinical trial.

Synthetic biology tools, like CRISPR and protein engineering, have helped scientists to build bacteria that can travel through the body, targeting and shrinking tumors with almost pinpoint precision. A new study from researchers at Columbia University has advanced these efforts further still.

San Diego-based Element Biosciences unveiled a commercial DNA sequencer last Monday. The device, called Aviti, could also be "adapted to study RNA, proteins, and cells," according to reporting by STAT.